The DOI matches its Crossref record.
A strategy for discovery of cancer glyco‐biomarkers in serum using newly developed technologies for glycoproteomics
Abstract
Detection of cancer at early stages that can be treated through surgery is a difficult task. One methodology for cancer biomarker discovery exploits the fact that glycoproteins produced by cancer cells have altered glycan structures, although the proteins themselves are common, ubiquitous, abundant, and familiar. However, as cancer tissue at the early stage probably constitutes less than 1% of the normal tissue in the relevant organ, only 1% of the relevant glycoproteins in the serum should have altered glycan structures. Here, we describe our strategy to approach the detection of these low‐level glycoproteins: (a) a quantitative real‐time PCR array for glycogenes to predict the glycan structures of secreted glycoproteins; (b) analysis by lectin microarray to select lectins that distinguish cancer‐related glycan structures on secreted glycoproteins; and (c) an isotope‐coded glycosylation site‐specific tagging high‐throughput method to identify carrier proteins with the specific lectin epitope. Using this strategy, we have identified many glycoproteins containing glycan structures that are altered in cancer cells. These candidate glycoproteins were immunoprecipitated from serum using commercially available antibodies, and their glycan alteration was examined by a lectin microarray. Finally, they were analyzed by multistage tandem MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
A systematic approach to protein glycosylation analysis: a path through the maze
Mariño, K., Bones, J., Kattla, J. J., & Rudd, P. M. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.437 · Cited by 628
Glycosylation, galectins and cellular signaling
Boscher, C., Dennis, J. W., & Nabi, I. R. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.05.001 · Cited by 341
Lectin microarrays: concept, principle and applications
Hirabayashi, J., Yamada, M., Kuno, A., & Tateno, H. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35419a · Cited by 303
Self-citationNew Technologies for Glycomic Analysis: Toward a Systematic Understanding of the Glycome
Rakus, J. F., & Mahal, L. K. (2011) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-061010-113951 · Cited by 117
Metadata
- Authors
- Narimatsu, H., Sawaki, H., Kuno, A., Kaji, H., Ito, H., & Ikehara, Y.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2009-12-15
- Volume
- 277
- Issue
- 1
- Pages
- 95-105
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W2118054188
- Cited by
- 169
- References
- 0
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A strategy for discovery of cancer glyco‐biomarkers in serum using newly developed technologies for glycoproteomics. https://app.cochat.ai/papers/10.1111/j.1742-4658.2009.07430.x
- The paper
- Narimatsu, H., Sawaki, H., Kuno, A., Kaji, H., Ito, H., & Ikehara, Y. (2010). A strategy for discovery of cancer glyco‐biomarkers in serum using newly developed technologies for glycoproteomics. The FEBS Journal. https://doi.org/10.1111/j.1742-4658.2009.07430.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.